Hydrochloride salt of 5-[3-(3-hydroxyphenoxy)azetidin-1-yl]-5 - methyl-2,2diphenylhexanamide

Details for Australian Patent Application No. 2008247095 (hide)

Owner Pfizer Limited

Inventors Glossop, Paul Alan; James, Kim

Agent Allens Arthur Robinson

Pub. Number AU-A-2008247095

PCT Pub. Number WO2008/135819

Priority 60/895,163 16.03.07 US

Filing date 6 March 2008

Wipo publication date 13 November 2008

International Classifications

C07D 205/04 (2006.01) Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom

A61K 31/397 (2006.01) - having four-membered rings, e.g. azetidine

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

Event Publications

3 September 2009 PCT application entered the National Phase

  PCT publication WO2008/135819 Priority application(s): WO2008/135819

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008247102-2 -pyridine carboxamide derivatives as sodium channel modulators

2008247068-Gender-specific, disposable, adultincontinence articles